Clobazam
Orphan DrugFDA Approved
Description
Clobazam is a benzodiazepine used as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome. It works by enhancing the effect of GABA, a neurotransmitter that inhibits brain activity, thereby reducing the frequency of seizures.
Indications & Therapeutic Use
Seizures associated with Lennox-Gastaut syndrome
Linked Diseases:
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Clobazam
| Generic Name | Clobazam |
| Brands | 1 brand available |
| Active Ingredient | Clobazam |
| Drug Class | Seizures associated with Lennox-Gastaut syndrome |
| Manufacturer | Lundbeck |
| Dosage Forms | Oral tablet, Oral suspension |
| Medical Code | N03AE01 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes